Chris Happé

1.4k total citations
21 papers, 941 citations indexed

About

Chris Happé is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Chris Happé has authored 21 papers receiving a total of 941 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 11 papers in Cardiology and Cardiovascular Medicine and 5 papers in Molecular Biology. Recurrent topics in Chris Happé's work include Pulmonary Hypertension Research and Treatments (18 papers), Cardiovascular Function and Risk Factors (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Chris Happé is often cited by papers focused on Pulmonary Hypertension Research and Treatments (18 papers), Cardiovascular Function and Risk Factors (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Chris Happé collaborates with scholars based in Netherlands, United States and France. Chris Happé's co-authors include Harm Jan Bogaard, Frances S. de Man, Anton Vonk Noordegraaf, Ingrid Schalij, Nina Rol, Nico Westerhof, Marie‐José Goumans, Willem J. van der Laarse, M. Louis Handoko and Kondababu Kurakula and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Chris Happé

20 papers receiving 921 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chris Happé Netherlands	15	717	525	208	100	69	21	941
C.H. Sattler France	11	778 1.1×	418 0.8×	197 0.9×	99 1.0×	65 0.9×	22	986
Nobuhiro Yaoita Japan	18	566 0.8×	439 0.8×	165 0.8×	95 0.9×	63 0.9×	38	913
Santhi Gladson United States	15	557 0.8×	187 0.4×	199 1.0×	91 0.9×	85 1.2×	25	742
Andrea L. Frump United States	17	527 0.7×	280 0.5×	173 0.8×	74 0.7×	55 0.8×	35	706
Nicholas Duggan United Kingdom	9	514 0.7×	187 0.4×	217 1.0×	83 0.8×	67 1.0×	16	709
Jennifer I. Drake United States	8	469 0.7×	314 0.6×	134 0.6×	90 0.9×	55 0.8×	11	569
Aysar Alhussaini United States	6	469 0.7×	194 0.4×	226 1.1×	84 0.8×	153 2.2×	8	641
Fares A. Masri United States	6	596 0.8×	222 0.4×	325 1.6×	70 0.7×	147 2.1×	8	817
Rasa Tamošiūnienė United States	11	718 1.0×	176 0.3×	176 0.8×	227 2.3×	109 1.6×	16	942
Jieyan Shen China	10	326 0.5×	215 0.4×	100 0.5×	76 0.8×	57 0.8×	26	483

Countries citing papers authored by Chris Happé

Since Specialization

Citations

This map shows the geographic impact of Chris Happé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Happé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Happé more than expected).

Fields of papers citing papers by Chris Happé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Happé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Happé. The network helps show where Chris Happé may publish in the future.

Co-authorship network of co-authors of Chris Happé

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Happé. A scholar is included among the top collaborators of Chris Happé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Happé. Chris Happé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Poot, Alex J., Esther Kooijman, Robert C. Schuit, et al.. (2023). Imaging the TGFβ type I receptor in pulmonary arterial hypertension. EJNMMI Research. 13(1). 23–23. 1 indexed citations

Jujo, Takayuki, Xiao‐Qing Sun, Chris Happé, et al.. (2021). Altered TGFβ/SMAD Signaling in Human and Rat Models of Pulmonary Hypertension: An Old Target Needs Attention. Cells. 10(1). 84–84. 19 indexed citations

Happé, Chris, Kondababu Kurakula, Xiao‐Qing Sun, et al.. (2020). The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient. Cells. 9(6). 1422–1422. 23 indexed citations

Kurakula, Kondababu, Xiao‐Qing Sun, Chris Happé, et al.. (2019). Prevention of progression of pulmonary hypertension by the Nur77 agonist 6-mercaptopurine: role of BMP signalling. European Respiratory Journal. 54(3). 1802400–1802400. 29 indexed citations

Rol, Nina, Kondababu Kurakula, Chris Happé, Harm Jan Bogaard, & Marie‐José Goumans. (2018). TGF-β and BMPR2 Signaling in PAH: Two Black Sheep in One Family. International Journal of Molecular Sciences. 19(9). 2585–2585. 83 indexed citations

Kojonazarov, Baktybek, Tatyana Novoyatleva, Mario Boehm, et al.. (2017). p38 MAPK Inhibition Improves Heart Function in Pressure-Loaded Right Ventricular Hypertrophy. American Journal of Respiratory Cell and Molecular Biology. 57(5). 603–614. 85 indexed citations

Sun, Xiao‐Qing, Kondababu Kurakula, Chris Happé, et al.. (2017). The effect of 6-mercaptopurine treatment on experimentally induced pulmonary arterial hypertension. Pure Amsterdam UMC. OA4660–OA4660. 1 indexed citations

Bós, Denielli da Silva Gonçalves, Chris Happé, Ingrid Schalij, et al.. (2017). Renal Denervation Reduces Pulmonary Vascular Remodeling and Right Ventricular Diastolic Stiffness in Experimental Pulmonary Hypertension. JACC Basic to Translational Science. 2(1). 22–35. 33 indexed citations

Szulcek, Robert, Chris Happé, Nina Rol, et al.. (2016). Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension: Role of Platelet Endothelial Cell Adhesion Molecule-1 Cleavage. American Journal of Respiratory and Critical Care Medicine. 193(12). 1410–1420. 73 indexed citations

10.

Happé, Chris, Michiel Alexander de Raaf, Nina Rol, et al.. (2016). Pneumonectomy combined with SU5416 induces severe pulmonary hypertension in rats. American Journal of Physiology-Lung Cellular and Molecular Physiology. 310(11). L1088–L1097. 22 indexed citations

11.

Happé, Chris, Robert Szulcek, N. F. Voelkel, & Harm Jan Bogaard. (2016). Reconciling paradigms of abnormal pulmonary blood flow and quasi-malignant cellular alterations in pulmonary arterial hypertension. Vascular Pharmacology. 83. 17–25. 8 indexed citations

12.

Happé, Chris, Peter Dorfmüller, Pia Trip, et al.. (2016). Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension. Circulation. 133(18). 1747–1760. 75 indexed citations

13.

Perros, Frédéric, Benoît Ranchoux, Mohamed Izikki, et al.. (2015). Nebivolol for Improving Endothelial Dysfunction, Pulmonary Vascular Remodeling, and Right Heart Function in Pulmonary Hypertension. Journal of the American College of Cardiology. 65(7). 668–680. 111 indexed citations

14.

Ruiter, Gerrina, Emmy Manders, Chris Happé, et al.. (2015). Intravenous Iron Therapy in Patients with Idiopathic Pulmonary Arterial Hypertension and Iron Deficiency. Pulmonary Circulation. 5(3). 466–472. 77 indexed citations

15.

Perros, Frédéric, Benoît Ranchoux, Mohamed Izikki, et al.. (2015). 0123 : Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension. Archives of Cardiovascular Diseases Supplements. 7(2). 216–216. 4 indexed citations

16.

Güçlü, Ahmet, Chris Happé, H. Ibrahim Korkmaz, et al.. (2015). Left ventricular outflow tract gradient is associated with reduced capillary density in hypertrophic cardiomyopathy irrespective of genotype. European Journal of Clinical Investigation. 45(12). 1252–1259. 22 indexed citations

17.

Happé, Chris, Robert Szulcek, Nina Rol, et al.. (2015). Caspase inhibition stabilizes progressive vascular remodeling in established pulmonary hypertension. PA4912–PA4912.

18.

Raaf, Michiel Alexander de, Jose Gomez‐Arroyo, Daniela Farkas, et al.. (2014). Histone Deacetylase Inhibition with Trichostatin a does not Reverse Severe Angioproliferative Pulmonary Hypertension in Rats (2013 Grover Conference Series). Pulmonary Circulation. 4(2). 1–7. 28 indexed citations

19.

Raaf, Michiel Alexander de, Ingrid Schalij, Jose Gomez‐Arroyo, et al.. (2014). SuHx rat model: partly reversible pulmonary hypertension and progressive intima obstruction. European Respiratory Journal. 44(1). 160–168. 70 indexed citations

20.

Handoko, M. Louis, Frances S. de Man, Chris Happé, et al.. (2009). Opposite Effects of Training in Rats With Stable and Progressive Pulmonary Hypertension. Circulation. 120(1). 42–49. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact